2025 Oncology Institute
May 3, 2025 | 4:11 AM EST
- Home
- Clinical Resources Search
- PQI: Management of Alpelisib (Piqray®) Induced Hyperglycemia
Management of Alpelisib (Piqray®) Induced Hyperglycemia
Download PQI pdf 0.52MB
Last Updated: December 19, 2023
By: Natasha Khrystolubova, RPh, BCOP | Jody Agena, PharmD
About this PQI
This PQI is intended to address effective practices for the management of alpelisib induced hyperglycemia by focusing on a multidisciplinary approach.

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 05/03/2025
PQI: Ibrutinib Dosing Optimization
Author: Nick Bouchard, PharmD | Danielle Maciorowski, PharmD
Last Updated: 05/03/2025
PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management
Author: Kayla Randle, PharmD, BCOP
Last Updated: 05/03/2025
PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Author: Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO
Last Updated: 05/03/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management
Author: Scripps Health, CA | UPMC, PA
Last Updated: 05/03/2025
PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations
Author: Florida Cancer Specialists & Research Institute, FL | Mayo Clinic, MN | Texas Oncology, TX
Last Updated: 05/03/2025
PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease
Author: University of Michigan Health-Sparrow Herbert-Herman Cancer Center, MI | Texas Oncology, TX | University of North Carolina (UNC) Health, NC
Last Updated: 05/03/2025
PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma
Author: Texas Oncology, TX | Florida Cancer Specialists & Research Institute, FL | University Hospitals Cleveland Medical Center, OH
Last Updated: 05/03/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
The PQI Podcast S8 Bonus Episode: ¡No Más Melanomas! – Updates in the Treatment of Cutaneous Melanoma
Author: Ginger Blackmon, PharmD | Kendra Rodriguez
Last Updated: 05/03/2025
The PQI Podcast S8 Ep 12: Lorlatinib in Practice: 5 Years of Data, Real-World Counseling, and AE Management
Author: Ginger Blackmon, PharmD | Stefanie Houseknecht, PharmD, BCOP | Monica Chintapenta, PharmD, BCOP
Last Updated: 05/03/2025
The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024
Author: Ginger Blackmon, PharmD | Madison Marsh
Last Updated: 05/03/2025
The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 05/03/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Abemaciclib
Last Updated: 05/03/2025
Treatment Support Kit: Temozolomide
Last Updated: 05/03/2025
Treatment Support Kit: Tivozanib
Last Updated: 05/03/2025
Treatment Support Kit: Regorafenib
Last Updated: 05/03/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 05/03/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Author: Brad Kahl, MD
Last Updated: 05/03/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Author: Jo Ellen Rodgers, PharmD, BCPS, BCCP
Last Updated: 05/03/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Author: Joyce O’Shaughnessy, MD
Last Updated: 05/03/2025
PQI
PQI
PQI
PQI
PQI: Tucatinib (Tukysa®) Management
Author: Katie Carter, PharmD, BCPS
Last Updated: 05/03/2025
PQI: The Role of Pharmacy in Equitable Breast Cancer Care
Author: Kayla Boyd, PharmD, BCOP | Daisy Doan, PharmD
Last Updated: 05/03/2025
PQI: Stomatitis Prophylaxis During Everolimus (Afinitor®) Therapy
Author: Matthew Schulz, PharmD
Last Updated: 05/03/2025
PQI: Sacituzumab govitecan (Trodelvy®): Management of Neutropenia and Diarrhea
Author: Rebecca Martin, PharmD, BCOP
Last Updated: 05/03/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI
The PQI Podcast S8 Bonus Episode: ¡No Más Melanomas! – Updates in the Treatment of Cutaneous Melanoma
Author: Ginger Blackmon, PharmD | Kendra Rodriguez
Last Updated: 05/03/2025
The PQI Podcast S8 Ep 12: Lorlatinib in Practice: 5 Years of Data, Real-World Counseling, and AE Management
Author: Ginger Blackmon, PharmD | Stefanie Houseknecht, PharmD, BCOP | Monica Chintapenta, PharmD, BCOP
Last Updated: 05/03/2025
The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024
Author: Ginger Blackmon, PharmD | Madison Marsh
Last Updated: 05/03/2025
PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 05/03/2025